Finance

Johnson & Johnson is seeking FDA approval to expand the use of its ketamine-based treatment, Spravato, for patients battling treatment-resistant depression. Learn how this innovative treatment could reshape the landscape for those who have struggled to find relief with traditional antidepressants. Curious about the results of the late-stage trial and the impact on patients? Read…

In a surprising twist following President Biden’s announcement not to seek re-election, the Democratic Party has experienced a remarkable surge in fundraising. Just one day later, they amassed $100 million through ActBlue, signaling a powerful grassroots movement and an energized donor base. With significant first-time contributions pouring in and Vice President Harris’s campaign gaining momentum,…

General Motors is making waves with its latest financial projections, raising expectations and boosting stock prices following impressive second-quarter results. Discover how CEO Mary Barra’s strategic moves in electric vehicles and joint ventures are shaping the future for the automotive giant, amid challenges and changes in the market. Click to unveil the full story!

A striking shift in GLP-1 drug prescriptions is unfolding, with an increase in those without diabetes receiving treatments originally designed for managing blood sugar. This trend is sparking concerns over potential medication shortages, especially for diabetes patients. As demand soars, pharmaceutical giants are racing to expand production. What does this mean for the future of…

Apple is reevaluating its hefty investments in original content for Apple TV+, as the streaming platform struggles to gain traction in a competitive market. After spending around $20 billion, the tech giant is reportedly shifting its strategy to rein in production costs and reshape its brand image. With a mere 0.2% share of U.S. television…

A shocking new report unveils how pharmacy-benefit managers (PBMs) may be steering patients towards pricier medications while limiting their choices. With an investigation stretching over two years, the findings raise serious questions about the influence these intermediaries wield in the pharmaceutical landscape. What could this mean for your health and wallet? Dive into the details…

Homebuyers are becoming increasingly cautious in today’s real estate market, leading to a surge in canceled purchase agreements. With rising costs and record-high home prices, many are re-evaluating their decisions. What factors are causing this shift in buyer behavior? Discover the latest trends and challenges shaping the housing landscape.

NVIDIA is making waves in the tech sector, emerging as a strong contender among major company stocks. With the looming challenges of the market and the political landscape, what sets NVIDIA apart? Dive into the latest analysis to discover how this semiconductor giant stands to benefit from the AI boom and what future projections could…

A groundbreaking partnership is set to transform the entrepreneurial landscape in Utah. Discover how the University of Utah and EPIC Ventures are joining forces to fuel innovation and drive economic growth through a new venture fund. This collaboration promises to bridge research with real-world applications—what could it mean for the future of technology and business…

As the political landscape shifts, Goldman Sachs suggests that Kamala Harris’ economic approach may closely mirror President Biden’s if she secures the Democratic nomination. With Biden stepping aside and endorsing Harris, the stakes are getting higher. What does this mean for fiscal policy and the upcoming election? Click to explore the implications of her potential…

This week has been a rollercoaster for several major companies, with Nvidia’s stock making headlines amid significant market fluctuations following political announcements. Discover how these developments are impacting tech giants and what the future could hold for sectors like AI and cybersecurity. Will Nvidia’s new chip strategy pay off? Click to explore the latest market…

A remarkable surge in fundraising for the Democratic Party marks a pivotal moment as President Biden announces he will not seek re-election. Discover how this unexpected shift has led to a record-breaking influx of donations and what it could mean for the future of party dynamics. Curious to learn more? Click to delve into the…

Are you struggling to get a good night’s sleep? You’re not alone. In a world full of distractions and stress, the quest for quality rest has led many to invest in sleep-enhancing products. But do they really work? Join Rocio Fabbro and sleep specialist Dr. Michael Breus as they unravel the science behind sleep, explore…

Delta Air Lines is under scrutiny as the Department of Transportation investigates widespread flight cancellations linked to a recent tech outage. With hundreds of passenger complaints pouring in, the airline’s struggles to regain normalcy post-crisis are raising questions about consumer care. What measures are being taken to address the fallout, and how is Delta managing…

General Motors is shaking things up with an upgraded financial outlook for 2024! After a strong second quarter, the automotive giant has boosted its earnings projections and is gearing up to launch new models. But not everything’s smooth sailing—challenges in the electric vehicle market and a shift in focus for its self-driving division raise questions…

Amazon’s ambitious plans for its Alexa-enabled devices are hitting some serious roadblocks, with reported losses reaching over $25 billion. As the online retail giant grapples with the challenge of turning a profit amidst widespread device usage for simple tasks, whispers of a potential paid tier for Alexa are surfacing. But could this be the answer,…

Wiz’s unexpected withdrawal from its $23 billion acquisition by Google could shake up the tech sector in ways you might not expect. As the Israeli cybersecurity startup redirects its focus towards ambitious revenue goals and a potential IPO, ripples are set to affect giants like Microsoft. Explore the implications of this bold decision and what…

Coca-Cola navigates shifting consumer trends as soda sales face headwinds from a rise in weight loss drugs and non-alcoholic beverages. Despite a slight volume decline in North America, the beverage giant reports impressive earnings, raising its sales forecasts. Discover how Coca-Cola is adapting to the market and what this means for its future amid a…

New findings from a House Committee investigation raise serious questions about the practices of pharmacy-benefit managers (PBMs) and their impact on medication costs. As executives prepare to testify on these allegations, shocking details emerge about how PBMs may prioritize expensive drugs over affordable alternatives. Could this be driving up drug prices and limiting patient choices?…

Hims & Hers is making waves in the healthcare landscape with the appointment of Kåre Schultz to its board of directors. His impressive pharmaceutical background coupled with the company’s innovative telehealth services is a game changer. Discover how their recent move into compounded medications could transform access to weight loss solutions. Don’t miss the story…

Ryanair’s latest earnings report has left investors disappointed, with stock prices plummeting 17%. Despite a surge in passenger numbers, the budget airline faces significant challenges, including increased labor costs and delayed aircraft deliveries. How will these factors shape the future of one of Europe’s leading low-cost carriers? Discover the implications of Ryanair’s current situation and…